245 related articles for article (PubMed ID: 32649856)
21. Thrombin induces platelet activation in the absence of functional protease activated receptors 1 and 4 and glycoprotein Ib-IX-V.
Lova P; Canobbio I; Guidetti GF; Balduini C; Torti M
Cell Signal; 2010 Nov; 22(11):1681-7. PubMed ID: 20600849
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of PAR4 signaling mediates ethanol-induced attenuation of platelet function in vitro.
Kasuda S; Sakurai Y; Shima M; Morimura Y; Kudo R; Takeda T; Ishitani A; Yoshioka A; Hatake K
Alcohol Clin Exp Res; 2006 Sep; 30(9):1608-14. PubMed ID: 16930224
[TBL] [Abstract][Full Text] [Related]
23. Genetic deletion of platelet PAR4 results in reduced thrombosis and impaired hemostatic plug stability.
Lee RH; Kawano T; Grover SP; Bharathi V; Martinez D; Cowley DO; Mackman N; Bergmeier W; Antoniak S
J Thromb Haemost; 2022 Feb; 20(2):422-433. PubMed ID: 34689407
[TBL] [Abstract][Full Text] [Related]
24. Thrombin receptor levels in platelet concentrates during storage and their impact on platelet functionality.
Schlagenhauf A; Kozma N; Leschnik B; Wagner T; Muntean W
Transfusion; 2012 Jun; 52(6):1253-9. PubMed ID: 22233332
[TBL] [Abstract][Full Text] [Related]
25. Thrombin-induced platelet activation via PAR4: pivotal role for exosite II.
Boknäs N; Faxälv L; Sanchez Centellas D; Wallstedt M; Ramström S; Grenegård M; Lindahl TL
Thromb Haemost; 2014 Sep; 112(3):558-65. PubMed ID: 24990072
[TBL] [Abstract][Full Text] [Related]
26. Contributions of Protease-Activated Receptors PAR1 and PAR4 to Thrombin-Induced GPIIbIIIa Activation in Human Platelets.
Duvernay MT; Temple KJ; Maeng JG; Blobaum AL; Stauffer SR; Lindsley CW; Hamm HE
Mol Pharmacol; 2017 Jan; 91(1):39-47. PubMed ID: 27784794
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.
Wu CC; Teng CM
Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935
[TBL] [Abstract][Full Text] [Related]
28. [Role of adenosine diphosphate in the course of thrombin signal transmission].
Han Y; Lu XX; Wang ZY; Dai L; Shen WH; Wu DP; Ruan CG
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3299-301. PubMed ID: 17313817
[TBL] [Abstract][Full Text] [Related]
29. Blockade of protease-activated receptor-4 (PAR4) provides robust antithrombotic activity with low bleeding.
Wong PC; Seiffert D; Bird JE; Watson CA; Bostwick JS; Giancarli M; Allegretto N; Hua J; Harden D; Guay J; Callejo M; Miller MM; Lawrence RM; Banville J; Guy J; Maxwell BD; Priestley ES; Marinier A; Wexler RR; Bouvier M; Gordon DA; Schumacher WA; Yang J
Sci Transl Med; 2017 Jan; 9(371):. PubMed ID: 28053157
[TBL] [Abstract][Full Text] [Related]
30. Thrombin-induced reactive oxygen species generation in platelets: A novel role for protease-activated receptor 4 and GPIbα.
Carrim N; Arthur JF; Hamilton JR; Gardiner EE; Andrews RK; Moran N; Berndt MC; Metharom P
Redox Biol; 2015 Dec; 6():640-647. PubMed ID: 26569550
[TBL] [Abstract][Full Text] [Related]
31. PAR1, but not PAR4, activates human platelets through a Gi/o/phosphoinositide-3 kinase signaling axis.
Voss B; McLaughlin JN; Holinstat M; Zent R; Hamm HE
Mol Pharmacol; 2007 May; 71(5):1399-406. PubMed ID: 17303701
[TBL] [Abstract][Full Text] [Related]
32. Antithrombotic effects of PAR1 and PAR4 antagonists evaluated under flow and static conditions.
Hosokawa K; Ohnishi T; Miura N; Sameshima H; Koide T; Tanaka KA; Maruyama I
Thromb Res; 2014 Jan; 133(1):66-72. PubMed ID: 24268424
[TBL] [Abstract][Full Text] [Related]
33. The contribution of thrombin-induced platelet activation to thrombus growth is diminished under pathological blood shear conditions.
Lee H; Sturgeon SA; Jackson SP; Hamilton JR
Thromb Haemost; 2012 Feb; 107(2):328-37. PubMed ID: 22187047
[TBL] [Abstract][Full Text] [Related]
34. C1-inhibitor influence on platelet activation by thrombin receptors agonists.
Tarandovskiy ID; Buehler PW; Karnaukhova E
Clin Appl Thromb Hemost; 2022; 28():10760296221120422. PubMed ID: 35996317
[TBL] [Abstract][Full Text] [Related]
35. Selective Inhibition of PAR4 (Protease-Activated Receptor 4)-Mediated Platelet Activation by a Synthetic Nonanticoagulant Heparin Analog.
Lin YC; Ko YC; Hung SC; Lin YT; Lee JH; Tsai JY; Kung PH; Tsai MC; Chen YF; Wu CC
Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):694-703. PubMed ID: 30727756
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory mediators modulate thrombin and cathepsin-G signaling in human bronchial fibroblasts by inducing expression of proteinase-activated receptor-4.
Ramachandran R; Sadofsky LR; Xiao Y; Botham A; Cowen M; Morice AH; Compton SJ
Am J Physiol Lung Cell Mol Physiol; 2007 Mar; 292(3):L788-98. PubMed ID: 17142351
[TBL] [Abstract][Full Text] [Related]
37. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.
Vretenbrant K; Ramström S; Bjerke M; Lindahl TL
Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509
[TBL] [Abstract][Full Text] [Related]
38. The C-Type Lectin Receptor CD93 Regulates Platelet Activation and Surface Expression of the Protease Activated Receptor 4.
Trivigno SMG; Vismara M; Canobbio I; Rustichelli S; Galvagni F; Orlandini M; Torti M; Guidetti GF
Thromb Haemost; 2024 Feb; 124(2):122-134. PubMed ID: 37669782
[TBL] [Abstract][Full Text] [Related]
39. A dual thrombin receptor system for platelet activation.
Kahn ML; Zheng YW; Huang W; Bigornia V; Zeng D; Moff S; Farese RV; Tam C; Coughlin SR
Nature; 1998 Aug; 394(6694):690-4. PubMed ID: 9716134
[TBL] [Abstract][Full Text] [Related]
40. A function-blocking PAR4 antibody is markedly antithrombotic in the face of a hyperreactive PAR4 variant.
French SL; Thalmann C; Bray PF; Macdonald LE; Murphy AJ; Sleeman MW; Hamilton JR
Blood Adv; 2018 Jun; 2(11):1283-1293. PubMed ID: 29884748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
